Warning letter
Terry Yon & Associates, Inc./dba Tya Pharmaceuticals [ARCHIVED]: warning letter of May 12, 2010
FDA warning letter 95666 · Florida District Office
Key facts
| Reference number | 95666 |
|---|---|
| Company | Terry Yon & Associates, Inc./dba Tya Pharmaceuticals [ARCHIVED] |
| Subject | CGMP/QSR/Manufacture/Packing/Storage/Installation/Adulterated |
| Issue date | May 12, 2010 |
| Posted date | May 12, 2010 |
| Issuing office | Florida District Office |
| Product type | Drugs |
| CFR sections cited | 211.166, 211.176, 211.42(c)(5), 211.42(d), 211.67(a), 211.137(a) |
| Inspection city | Tallahassee |
| Inspection ZIP | 32301 |
| Inspection start date | Nov 16, 2009 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: